retatrutide clinical trials mechanism 40mg Pen | Triple G Weight Management | Premio Peptides Today, we shared new data

State Medicaid programs can still opt out of covering the obesity indications, and only 13 states covered GLP-1s for obesity under fee-for-service as of January 2026 ( [3] )

Members receive personalized nutrition guidance to help them meet important macronutrient goals, tools to track weight loss and medication doses, strategies and support for managing side effects, and strength-building plans to help preserve muscle mass

This is where things became even more confusing

Below, we break down what long-term GLP-1 use really means, how to think about discontinuation, and what supports lasting weight stability

Claims about GLP-1 support rely on marketing language, placebo effects, or unproven ingredients rather than rigorous human trials